{"title":"Physicochemical mechanisms of aggregation and fibril formation of α-synuclein and apolipoprotein A-I.","authors":"Takashi Ohgita, Hiroki Kono, Norihiro Namba, Hiroyuki Saito","doi":"10.2142/biophysico.bppb-v21.0005","DOIUrl":null,"url":null,"abstract":"<p><p>Deposition and accumulation of amyloid fibrils is a hallmark of a group of diseases called amyloidosis and neurodegenerative disorders. Although polypeptides potentially have a fibril-forming propensity, native proteins have evolved into proper functional conformations to avoid aggregation and fibril formation. Understanding the mechanism for regulation of fibril formation of native proteins provides clues for the rational design of molecules for inhibiting fibril formation. Although fibril formation is a complex multistep reaction, experimentally obtained fibril formation curves can be fitted with the Finke-Watzky (F-W) two-step model for homogeneous nucleation followed by autocatalytic fibril growth. The resultant F-W rate constants for nucleation and fibril formation provide information on the chemical kinetics of fibril formation. Using the F-W two-step model analysis, we investigated the physicochemical mechanisms of fibril formation of a Parkinson's disease protein α-synuclein (αS) and a systemic amyloidosis protein apolipoprotein A-I (apoA-I). The results indicate that the C-terminal region of αS enthalpically and entropically suppresses nucleation through the intramolecular interaction with the N-terminal region and the intermolecular interaction with existing fibrils. In contrast, the nucleation of the N-terminal fragment of apoA-I is entropically driven likely due to dehydration of large hydrophobic segments in the molecule. Based on our recent findings, we discuss the similarity and difference of the fibril formation mechanisms of αS and the N-terminal fragment of apoA-I from the physicochemical viewpoints.</p>","PeriodicalId":101323,"journal":{"name":"Biophysics and physicobiology","volume":"21 1","pages":"e210005"},"PeriodicalIF":1.6000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128303/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biophysics and physicobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2142/biophysico.bppb-v21.0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Deposition and accumulation of amyloid fibrils is a hallmark of a group of diseases called amyloidosis and neurodegenerative disorders. Although polypeptides potentially have a fibril-forming propensity, native proteins have evolved into proper functional conformations to avoid aggregation and fibril formation. Understanding the mechanism for regulation of fibril formation of native proteins provides clues for the rational design of molecules for inhibiting fibril formation. Although fibril formation is a complex multistep reaction, experimentally obtained fibril formation curves can be fitted with the Finke-Watzky (F-W) two-step model for homogeneous nucleation followed by autocatalytic fibril growth. The resultant F-W rate constants for nucleation and fibril formation provide information on the chemical kinetics of fibril formation. Using the F-W two-step model analysis, we investigated the physicochemical mechanisms of fibril formation of a Parkinson's disease protein α-synuclein (αS) and a systemic amyloidosis protein apolipoprotein A-I (apoA-I). The results indicate that the C-terminal region of αS enthalpically and entropically suppresses nucleation through the intramolecular interaction with the N-terminal region and the intermolecular interaction with existing fibrils. In contrast, the nucleation of the N-terminal fragment of apoA-I is entropically driven likely due to dehydration of large hydrophobic segments in the molecule. Based on our recent findings, we discuss the similarity and difference of the fibril formation mechanisms of αS and the N-terminal fragment of apoA-I from the physicochemical viewpoints.
淀粉样蛋白纤维的沉积和积累是一组被称为淀粉样变性病和神经退行性疾病的标志。虽然多肽可能具有形成纤维的倾向,但原生蛋白质已进化成适当的功能构象,以避免聚集和纤维的形成。了解原生蛋白质纤维形成的调控机制为合理设计抑制纤维形成的分子提供了线索。虽然纤维形成是一个复杂的多步反应,但实验得到的纤维形成曲线可以用芬克-瓦茨基(Finke-Watzky,F-W)两步模型来拟合,即先均匀成核,然后自催化纤维生长。由此得出的成核和纤维形成的 F-W 速率常数可提供纤维形成的化学动力学信息。利用 F-W 两步模型分析,我们研究了帕金森病蛋白 α-突触核蛋白(αS)和系统性淀粉样变性蛋白载脂蛋白 A-I(apoA-I)纤维形成的物理化学机制。研究结果表明,αS 的 C 端区域通过与 N 端区域的分子内相互作用以及与现有纤维的分子间相互作用,在焓和熵方面抑制了成核。相比之下,apoA-I N 端片段的成核是由熵驱动的,这可能是由于分子中大的疏水片段脱水所致。根据我们最近的研究结果,我们从物理化学的角度讨论了 αS 和 apoA-I N 端片段纤维形成机制的异同。